| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 5,515 | 5,493 | 9,544 | 5,947 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 5,515 | 5,493 | 9,544 | 5,947 | | | Operating Expenses | | Research Development | 19,541 | 20,020 | 19,557 | 15,170 | | Selling General and Administrative | 7,061 | 6,796 | 7,052 | 5,945 | | Non Recurring | (6) | 30 | 1,283 | 306 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (21,081) | (21,353) | (18,348) | (15,474) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 413 | 1,172 | 647 | 1,066 | | Earnings Before Interest And Taxes | (20,668) | (20,181) | (17,701) | (14,408) | | Interest Expense | 1,515 | 1,511 | 1,516 | 1,517 | | Income Before Tax | (22,183) | (21,692) | (19,217) | (15,925) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (22,183) | (21,692) | (19,217) | (15,925) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (22,183) | (21,692) | (19,217) | (15,925) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($22,183) | ($21,692) | ($19,217) | ($15,925) |
|
0.51% Nasdaq 
0.41 (3.00%) 
Income Statement
